{"chunk_id": "medquad__chunk_28807", "source": "medquad", "text": "t plasma therapy reduces mortality significantly and anectodal evidence from the only surviving Lujo patient shows that the antiviral drug ribavirin may hold promise in the treatment of LUHF. Ribavirin has been considered for preventing development of disease in people exposed to other arenaviruses. \n   Recovery \n   \nThe precise mortality of LUHF is unknown, but 4 of 5 described cases were fatal. \n   \nPatients who have suffered from other arenaviruses may excrete virus in urine or semen for week"}